<SEC-DOCUMENT>0000000000-23-008113.txt : 20231013
<SEC-HEADER>0000000000-23-008113.hdr.sgml : 20231013
<ACCEPTANCE-DATETIME>20230728143006
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000000000-23-008113
CONFORMED SUBMISSION TYPE:	UPLOAD
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230728

FILED FOR:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Envoy Medical, Inc.
		CENTRAL INDEX KEY:			0001840877
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				861369123
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		UPLOAD

	BUSINESS ADDRESS:	
		STREET 1:		4875 WHITE BEAR PARKWAY
		CITY:			WHITE BEAR LAKE
		STATE:			MN
		ZIP:			55110
		BUSINESS PHONE:		651-361-8000

	MAIL ADDRESS:	
		STREET 1:		4875 WHITE BEAR PARKWAY
		CITY:			WHITE BEAR LAKE
		STATE:			MN
		ZIP:			55110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anzu Special Acquisition Corp I
		DATE OF NAME CHANGE:	20210115
PUBLIC REFERENCE ACCESSION NUMBER:		0001104659-23-060442
</SEC-HEADER>
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
<PDF>
begin 644 filename1
M)5!$1BTQ+C4*)>+CS],*,2 P(&]B:@H\/"]#;VQO<E-P86-E+T1E=FEC94=R
M87DO4W5B='EP92]);6%G92](96EG:'0@,C0W+T9I;'1E<B]&;&%T941E8V]D
M92]4>7!E+UA/8FIE8W0O5VED=&@@,30R."],96YG=&@@,S8U+T)I='-097)#
M;VUP;VYE;G0@.#X^<W1R96%M"GB<[<&!     ,,@?^K=X 15 0
M
M
M
M
M
M
M
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M"U83J5T@@&P1%G"3H7!4FZX<NV,R$6PM:#;"!>>"GG!Q%%,ZAPK16+#E0+[
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MK:3?LM9=:]I%7O<^\N1EVL52)E3-B5RI732RP&YZQ7L;E9L\(;>$JFY"4DQ
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M[DJ(3BP \P1YT[%F@K@_ABI=CEE6:YUI+I*V?YA>X&ASX6TA(B(B(B(B\M>
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M1$1$KB?C-C1+]9I!-8GU^)I9PNOK:]9018]8[/]M"D8T[_[^OMJ3/#T]I?Y
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M2"6M9RS,,2T@#VF6G&@7I$\=I@Y95F)U(HP0&H*#LJ6&_5PZ[6(I\D54>'^
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M_%OP$@!+G2BA5)/']EE5-S59,:*9SP/'-:I\E+6AB*'DMXM<GJ1((T)NZO'
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M5"XR:&NI] 9>=U1X+&(OKN9]828+CQ%-9@N25,^J4#6("RW.Q^2I[1(V .X
M;@:;?9)<MMS7M?HD3AQ)?5&K]UE[F:@O.OY0-4(B0<!&4Z>;K<)R;N:6:D["
M19!<Z29WL=2V6Z_+B(!ZN/TN8-D3,EE,''W>R1P@YP98 B@XN4X<RS,.THJ,
M>[R"CN6VNH(L,BRW!,"A%_L:/)F'7OJ0 *@/A,2XA.8N"6,&U$F"C2Q\% IV
MBL(5:'6.<X><E>1 ?>IX[I"^D&GJ-1 ":UO ]OC)FR4766B2^0$90-4Q[B L
M#U,'NLZ6#_G($Q3VU!=N&GD1M&&61"ROKSIS55,VI@&UH'D;AQ1K*=FVG>D\
M80FUV>)(V$;5GG[Z8B8S#YZ7LCHX5 YV60*\3_\G?99$T=5@-]QG?=:OVX%W
MD++ _SO%XL>]9W%@!P_@'51D0<1+SF4-CCW%BQ>IY["WMF*:[& ,^LTQ>%6K
MANQI<(A<Y7A? SL$L6AJ+X NW/#@'<]CKVK77>.!=&X !LR89] MK$ZXY+8J
MJ/9$  5JX=O79''J\O&"I,J<!R^"'/\)VM"$\9)<AF=JZ(LV3;R@=6FC8HTL
M5*9JZ$A7$@>$!WJ*\[)* UJU.?;%PJW>R5KU7*B5&\PYF+O_G([;MX\F^"0>
MDU9(M5%UU1ALIZVYRVVUKH7EKKYXL;^IW75X+;C9#T.7P?_?^S"83<5^A/MN
M'#+[;D8 2(!;FGODWT;X=Y&7MW7<ECGOZS>XWF?=+GW([(CPK1'_DOH#^/+G
M[;;2=5-B#(#X\,TZFL^[M3U%/_N[C]"$>-?^=C"42G>/O'=XOJ*-/\=6SLUL
M&D27M!>EPS3)"RYO'N^)N8':_D+W.'"N==6LUHXM@$3C94NQSMB9R7;+EE<
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M-SX^<W1R96%M"GB<K57;<MHP$'WW5^Q;Z4Q0;1E9IF\A:=*DG>8",YD^:HP
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7"G-T87)T>')E9@HS.30R.0HE)45/1@H!

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
United States securities and exchange commission logo





                             July 28, 2023

       Dr. Whitney Haring-Smith
       Chief Executive Officer
       Anzu Special Acquisition Corp I
       12610 Race Track Road, Suite 250
       Tampa, FL 33626

                                                        Re: Anzu Special
Acquisition Corp I
                                                            Amendment No. 1 to
Registration Statement on Form S-4
                                                            Filed June 30, 2023
                                                            File No. 333-271920

       Dear Dr. Whitney Haring-Smith:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our June
13, 2023 letter.

       Amendment No. 1 to Registration Statement on Form S-4 Filed June 30,
2023

       Q. Will Anzu enter into any financing arrangements in connection with
the Business
       Combination?, page xiv

   1.                                                   We note your amended
disclosure in response to comment 2. Please briefly describe the
                                                        "ertain customary
adjustments in the event of certain events affecting the price of the New
                                                        Envoy Class A Common
Stock."
       Interests of the Sponsor and Anzu's Directors and Officers in the
Business Combination, page 11

   2.                                                   We note your response
to previous comment 25, but we are not persuaded by your
                                                        response. Please
provide your analysis of how purchases under your forward purchase
                                                        agreement will comply,
and how the extension support agreements described at the
 Dr. Whitney Haring-Smith
FirstName  LastNameDr.
Anzu Special  AcquisitionWhitney
                         Corp I Haring-Smith
Comapany
July       NameAnzu Special Acquisition Corp I
     28, 2023
July 28,
Page  2 2023 Page 2
FirstName LastName
         bottom of page 11 comply, with Rule 14e-5. Specifically, please
provide additional detail
         explaining how the agreement satisfies the requirement in the
exemption in 14e-5(b)(7)(ii)
         that the agreement is "unconditional and binding on both parties,"
given your disclosure
         that "[p]ursuant to the terms of the Forward Purchase Agreement,
Seller intends, but is not
         obligated, to purchase . . . shares of Anzu Class A Common Stock"
(emphasis added).
         Alternatively, please provide the disclosure required by Tender Offer
Compliance and
         Disclosure Interpretation 166.01 (March 22, 2022), and ensure that the
required conditions
         are met.
Risk Factors
Certain of our directors, director nominees . . ., page 36

3.       We note your amended disclosure in response to comment 13. Please
amend your
         disclosure to briefly describe the duties or obligations of the
relevant directors with
         respect to the entities discussed, including fiduciary duties or
contractual obligations.
The Proposed Charter will provide that the Court of Chancery . . ., page 80

4.       Please revise this risk factor, and your discussion of the warrant
agreement exclusive
         forum provision on page 251, to disclose the risks that the exclusive
forum provision
         may both limit a warrant holder's ability to bring a claim and
potentially increase costs for
         investors to bring a claim.
Unaudited Pro Forma Condensed Combined Financial Statements, page 129

5.       We note your response to comment 19. Please expand your disclosure to
discuss the
         impact to the financial statements on a pro forma basis should the
working capital loan be
         converted into warrants.
6.       We note your response to comment 20, please clarify the reason that
the $10 million
         convertible promissory note with the shareholder is not presented as a
liability on the pro
         forma balance sheets, given the note will be funded prior to the
merger and the maturity
         date is December 31, 2025.
Representations, Warranties, and Covenants, page 144

7.       We note your amended disclosure in response to comment 22, including
"material
         representations and warranties: . . . litigation and actions pending
or threated against . . .
         Envoy or any settlements related thereto." Given your risk factor
disclosure that Envoy is
         currently a party to litigation, please clarify the representation or
warranty related to
         litigation and the potential impact, if any, of the disclosed
litigation on the merger
         agreement.
8.       We note your amended disclosure on page 144 that the representations
and warranties
         included a representation by Anzu that there would be at least
$43,913,470 in the
         trust account. Please amend your filing, including your risk factors
and background of the
 Dr. Whitney Haring-Smith
Anzu Special Acquisition Corp I
July 28, 2023
Page 3
         business combination, to disclose this minimum cash condition. In your
background
         discussion, please disclose how the parties arrived at this minimum
cash condition,
         including any negotiations and relative positions of each party to the
merger.
Background of the Business Combination, page 159

9.       We note your revisions in response to previous comment number 28 and
reissue the
         comment. Please revise your disclosure throughout this section to
include detailed
         descriptions of negotiations relating to material terms of the
business combination and
         related transactions, including, but not limited to, the key terms of
the PIPE Transaction;
         the Sponsor Support Agreement, including the Sponsor agreeing to
forfeit certain
         securities; the proposed Envoy Conversions and the cancellation of
outstanding Envoy
         options for nominal consideration; the determination to enter into the
Forward Purchase
         Agreement and the key terms of the agreement, including the Shortfall
Warrants; the
         determination to enter into the Envoy Bridge note and the key terms of
the note, including
         the purpose of the note and any conflicts of interest considered; the
initial valuation for
         Envoy of $150.0 million and any related negotiations; the agreements
with Key
         Shareholders; and the Exchange Offer. In your revised disclosure,
please explain the
         reasons for such agreements and terms, each party's position on such
issues, and how you
         reached agreement on the final terms and agreements. For example,
where you disclose
         statements such as "[p]rincipal terms were discussed, including what
terms would be
         acceptable to shareholders for Envoy and Anzu," describe the terms,
negotiations, each
         party's position on these issues, and ultimately how the parties came
to a final agreement.
         This is one example only, and changes should be made to your
discussion throughout this
         section.
10.      We note your disclosure in response to comment 33 that Anzu engaged
MCRA to conduct
         diligence with respect to the Acclaim implant device and its potential
for insurance
         reimbursement. Please disclose whether the Anzu board received a due
diligence report
         from MCRA, and if so, please provide the information required by Item
4(b) of Form S-4
         and Item 1015(b) of Regulation M-A, or tell us why you do not believe
you are required
         to do so.
Side Letters with Legacy Forward Purchasers, page 159

11.    We note your amended disclosure in response to comment 27, including
that
       "[n]otwithstanding the termination of the Legacy Forward Purchase
Agreements described
       above, the side letter agreements between Anzu and the Legacy Forward
Purchasers
       remain in full force and effect as of the date of this proxy
statement/prospectus." Please
       clarify the purpose of the side letter agreements, including why these
agreements remain
FirstName LastNameDr. Whitney Haring-Smith
       in full force and effect notwithstanding the termination of the Legacy
Forward Purchase
Comapany     NameAnzu
       Agreements.          Special
                        Please  alsoAcquisition
                                     file the sideCorp
                                                   letterI agreements as
exhibits to your registration
July 28,statement
          2023 Pageor 3tell us why you believe you are not required to do so.
FirstName LastName
 Dr. Whitney Haring-Smith
FirstName  LastNameDr.
Anzu Special  AcquisitionWhitney
                         Corp I Haring-Smith
Comapany
July       NameAnzu Special Acquisition Corp I
     28, 2023
July 28,
Page  4 2023 Page 4
FirstName LastName
The Anzu Board's Reasons for the Business Combination, page 167

12.      We note your response to previous comment 34 and reissue in part.
Please amend your
         disclosure to describe the Board's reasoning in deciding to forego
obtaining a fairness
         opinion and describe the relevant expertise of the board members.
Also, please identify
         the management and financial, legal, tax and accounting advisors
consulted by
         management to the extent any differ from those discussed in the
Background of the
         Business Combination section.
13.      We note the your revisions in response to previous comment 35,
including that the Anzu
         Board considered, among other factors, the revenues, earnings and
market capitalizations
         of the incumbent competitors currently selling partially-implanted
medical devices, and
         the capture of market share by analogous medical device companies.
Please revise to
         describe the Board's methodology for identifying comparable companies
and describe the
         analyses performed to arrive at the valuation of Envoy. Additionally,
please remove the
         reference to other public listing transactions and their valuation
methods or explain how
         the valuations of these other companies are relevant to Envoy's
valuation. Finally, please
         clarify why the opportunity for holders of Anzu Class A Common Stock
to exchange their
         shares for Series A Preferred Stock provided additional comfort that
the valuation of
         Envoy was reasonable.
14.      We note your disclosure referencing "[t]hird party diligence
providers" and industry-
         relevant consultants, including that these entities provided diligence
regarding the
         potential timing for FDA approval and reimbursement. Please revise to
identify these
         providers.
Management's Discussion and Analysis of Financial Condition and Results of
Operations of
Anzu
Liquidity and Capital Resources, page 180

15.      We note your response to comment 37, including your amended disclosure
that "following
         industry developments, one of the two underwriters from our initial
public offering
         unconditionally resigned and $4,462,500 of the $14,875,000 deferred
underwriter discount
         was forgiven. In February 2023, the remaining underwriter resigned
from its role in the
         Business Combination and thereby waived its entitlement to $10,412,500
in deferred
         underwriting fees solely with respect to the Business Combination."
Please identify the
         relevant underwriters in your disclosure and provide a detailed
discussion of the reasons
         underlying the resignation of both of these underwriters, including
the "industry
         developments" that caused one of the two underwriters to resign, and
the reasons
         underlying the resignation of the second underwriter. In your
discussion, and where
         appropriate throughout your registration statement, please address the
following:

                We understand that the underwriters in your SPAC IPO intend to
waive the deferred
              underwriting commissions that would otherwise be due to them upon
the closing of
 Dr. Whitney Haring-Smith
FirstName  LastNameDr.
Anzu Special  AcquisitionWhitney
                         Corp I Haring-Smith
Comapany
July       NameAnzu Special Acquisition Corp I
     28, 2023
July 28,
Page  5 2023 Page 5
FirstName LastName
              the business combination. Please disclose how this waiver was
obtained, why the
              waiver was agreed to, and clarify the SPAC   s current
relationship with the
              underwriters.

                Please describe what relationship existed between the
underwriters and Anzu after the
              close of the IPO, including any financial or merger-related
advisory services
              conducted by the underwriters. For example, clarify whether the
underwriters had
              any role in the identification or evaluation of business
combination targets.

                Tell us whether the underwriters were involved in the
preparation of any disclosure
              that is included in the Form S-4 registration statement,
including any analysis
              underlying disclosure in the registration statement. If so,
clarify their involvement,
              whether they have retracted any work product associated with the
transaction, and the
              risk of such withdrawal and reliance on their expertise. Further,
please clarify that
              whether the underwriters claim no role in the SPAC   s business
combination
              transaction and whether the underwriters have affirmatively
disclaimed any
              responsibility for any of the disclosure in this registration
statement.

                Please tell us whether you are aware of any disagreements with
the
              underwriters regarding the disclosure in your registration
statement. Further, please
              add risk factor disclosure that clarifies that the underwriters
were to be compensated,
              in part, on a deferred basis for its underwriting services in
connection with the SPAC
              IPO and such services have already been rendered, yet the
underwriters are waiving
              such fees. Clarify the unusual nature of such a fee waiver and
the impact of it on the
              evaluation of the business combination.

                Disclose whether the underwriters provided you with any reasons
for the fee waiver.
              If there was no dialogue and you did not seek out the reasons why
the
              underwriters were waiving deferred fees, despite already
completing their services,
              please indicate so in your registration statement. Further,
revise the risk factor
              disclosure to explicitly clarify that the underwriters have
performed all their
              obligations to obtain the fee and therefore is gratuitously
waiving the right to be
              compensated.
Acclaim's Market Opportunity, page 188

16.      We note your revisions throughout this section in response to previous
comment 38 and
         reissue in part. Please provide a citation to the referenced articles
and, at each source's
         first instance, include language summarizing the material conclusions
of such literature.
         With regard to citations, footnotes may be useful.
17.      We note your response to comment 39, and your amended disclosure in
response to the
         comment that "although the process of obtaining FDA approval is
uncertain, and we may
         not obtain approval on that timeline or at all; and "FDA approval is
not guaranteed and
 Dr. Whitney Haring-Smith
Anzu Special Acquisition Corp I
July 28, 2023
Page 6
         each step of the process may take longer than we have planned." Please
amend your
         disclosure, here and throughout the description of Envoy's business
and market
         opportunity, to provide a detailed discussion of the challenges you
face in corporate
         growth, distribution capabilities and partnerships, and product
development, if regulatory
         approvals are delayed or not received. This disclosure should balance
your prominent
         discussions of your device's competitive strengths.
Market Competition, page 189

18.      We note your disclosure here that Cochlear Ltd. is the leading
cochlear implant device
         manufacturer with approximately 60% of global market share, and your
disclosure that
         "[w]hile there is some overlap between hearing aid and cochlear
implant use, candidates
         for cochlear implants are no longer appropriate hearing aid
candidates. As a result, we
         believe the competition between hearing aid and cochlear implant
manufacturers for the
         same clinical patient population is minimal." Given your disclosure
that Cochlear Ltd. is
         a cochlear implant device manufacturer, please clarify the relevance
of your above
         statement about hearing aids. In addition, please describe your
competitive position with
         respect to the other of the "three major cochlear implant
manufacturers."
General

19.      Where appropriate throughout your filing, including but not limited to
your risk factors,
         please disclose certain interests of the Envoy directors and officers,
to include, but not
         limited to, a reference to the GAT Convertible Note, including that
this note will convert
         into 74.8 million shares of Envoy common stock immediately prior to
the business
         combination, and the relationship between Randy Nitzsche, Glen Taylor,
and Northland
         Securities, Inc. Refer to Item 18(a)(5)(i) of Form S-4.
20.      We note your amended disclosure in response to comment 88. Please
provide a maximum
         redemption scenario, or tell us why you do not believe you are
required to do so.
21.    We note your response to comment 49, and your amended disclosure on
pages 5 and 60 of
       the registration statement. However, your amended disclosure does not
appear to
       be completely responsive to our comment. Please disclose all possible
sources and extent
       of dilution that shareholders who elect not to redeem their shares may
experience in
       connection with the business combination. Provide disclosure of the
impact of each
       significant source of dilution, including the amount of equity held by
founders,
       convertible securities, including warrants retained by redeeming
shareholders, at each of
FirstName LastNameDr. Whitney Haring-Smith
       the redemption levels detailed in your sensitivity analysis, including
any needed
Comapany    NameAnzu
       assumptions.      Special
                      Your       Acquisition
                             presentation     Corp
                                          should   I the impact on each
entity's relative
                                                 show
July 28,ownership
         2023 Pagein6the combined company for each significant source of
dilution.
FirstName LastName
 Dr. Whitney Haring-Smith
FirstName  LastNameDr.
Anzu Special  AcquisitionWhitney
                         Corp I Haring-Smith
Comapany
July       NameAnzu Special Acquisition Corp I
     28, 2023
July 28,
Page  7 2023 Page 7
FirstName LastName
       You may contact Christie Wong at 202-551-3684 or Terence O'Brien at
202-551-3355 if
you have questions regarding comments on the financial statements and related
matters. Please
contact Benjamin Richie at 202-551-7857 or Katherine Bagley at 202-551-2545
with any other
questions.



                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Industrial
Applications and
                                                          Services
cc:      David Slotkin
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
